NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Oxford BioDynamics Plc (LSE: OBD)
OBD Technical Analysis
5
As on 25th Apr 2025 OBD STOCK Price closed @ 0.42 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 12.90 & Strong Sell for SHORT-TERM with Stoploss of 27.75 we also expect STOCK to react on Following IMPORTANT LEVELS. |
OBDSTOCK Price
Open | 0.42 | Change | Price | % |
High | 0.45 | 1 Day | -0.03 | -6.67 |
Low | 0.40 | 1 Week | -0.03 | -6.67 |
Close | 0.42 | 1 Month | -0.06 | -12.50 |
Volume | 8007259 | 1 Year | -33.58 | -98.76 |
52 Week High 35.00 | 52 Week Low 0.38 |
LSE UK Most Active Stocks
PREM | 0.04 | 0.00% |
UKOG | 0.01 | 0.00% |
VAST | 0.44 | 0.00% |
TRP | 0.03 | 0.00% |
DEMG | 0.02 | -50.00% |
SEE | 1.75 | 2.94% |
SMDS | 582.50 | 0.00% |
DKE | 0.15 | 0.00% |
SYME | 0.00 | % |
NNN | 0.09 | 50.00% |
LSE UK Top Gainers Stocks
LSE UK Top Losers Stocks
OBD Daily Charts |
OBD Intraday Charts |
Whats New @ Bazaartrend |
OBD Free Analysis |
|
OBD Important Levels Intraday
RESISTANCE | 0.52 |
RESISTANCE | 0.49 |
RESISTANCE | 0.47 |
RESISTANCE | 0.45 |
SUPPORT | 0.39 |
SUPPORT | 0.37 |
SUPPORT | 0.35 |
SUPPORT | 0.32 |
OBD Forecast April 2025
4th UP Forecast | 46.48 |
3rd UP Forecast | 31.71 |
2nd UP Forecast | 22.58 |
1st UP Forecast | 13.45 |
1st DOWN Forecast | -12.61 |
2nd DOWN Forecast | -21.74 |
3rd DOWN Forecast | -30.87 |
4th DOWN Forecast | -45.64 |
OBD Weekly Forecast
4th UP Forecast | 15.84 |
3rd UP Forecast | 10.89 |
2nd UP Forecast | 7.84 |
1st UP Forecast | 4.78 |
1st DOWN Forecast | -3.94 |
2nd DOWN Forecast | -7.00 |
3rd DOWN Forecast | -10.05 |
4th DOWN Forecast | -15.00 |
OBD Forecast2025
4th UP Forecast | 70.81 |
3rd UP Forecast | 48.24 |
2nd UP Forecast | 34.28 |
1st UP Forecast | 20.33 |
1st DOWN Forecast | -19.49 |
2nd DOWN Forecast | -33.44 |
3rd DOWN Forecast | -47.4 |
4th DOWN Forecast | -69.97 |
Oxford BioDynamics Plc ( LSE UK Symbol : OBD )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
OBD Other Details
Segment | EQ | |
Market Capital | 43271704.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
OBD Address
![]() |
OBD Latest News
OBD Business Profile
Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and internationally. The company provides EpiSwitch, a proprietary technology platform for the discovery, evaluation, validation, and monitoring of epigenetic biomarkers known as chromosome conformation signatures. It has collaboration agreements with the University of Glasgow for prognostic and predictive profiling of COVID-19 patients in the GETAFIX. Oxford BioDynamics Plc was founded in 2007 and is headquartered in Oxford, the United Kingdom. Address: 3140 Rowan Place, Oxford, United Kingdom, OX4 2WB
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service